Leo Cancer Care has developed a unique groundbreaking upright positioning system that can be combined with a fixed radiation beam and upright scanner, removing the need for large and expensive rotating gantries.
Leo Cancer Care’s pioneering Proton Therapy and Photon Therapy solutions, MarieTM, RubyTM and AdaTM have been developed using research and evidence from across the globe, demonstrating the clinical benefits of upright patient positioning through reduced organ motion. These solutions have been designed with the patient in mind as the upright position is easier and quicker to set up, whilst also being more empowering for the patient and enables better, eye-to-eye communication with clinicians.
”We founded Leo Cancer Care to improve both the quality and access to Radiation Therapy. We are delighted to be partnering with Mercurius Health to launch the Leo technology into European markets. Together we have the innovative technology and combined experience in the Radiation Oncology field to make a real difference to cancer patients”.Stephen Towe, CEO at Leo Cancer Care
Mercurius Health is a B2B services provider that supports hospitals and cancer treatment centres to provide the highest quality care for their patients, by making the best use of advanced and rapidly changing technology. Mercurius Health are the market leader in Portugal where they have over 20 years of experience in supporting public and private oncology institutions through a team of over 120 oncology professionals. The Mercurius Health team constitutes one of the world’s largest networks of specialized Radiotherapy and Nuclear Medicine staff and has an unrivalled methodology in how to manage radiotherapy departments and clinics within strict EU level regulatory frameworks.
“We are delighted to be able to support Leo Cancer Care in their deployment of MarieTM, RubyTM and AdaTM in Europe and look forward to working with the team in order to obtain all local regulatory and CE approvals to allow successful marketing of solutions we truly believe will bring significant improvements to patient care. The future launch of a mobile RT treatment unit based on the Leo Cancer Care technology is a much-awaited step forward in bringing access to those patients who currently must travel significant distances for treatment”.John Allen, CEO at Mercurius Health
Both businesses share a common goal, to improve the patient experience and utilization of new technologies for the treatment of cancer patients across Europe, whilst also making sure that as many people get access to the best quality of cancer care and treatment as possible. This is a partnership built on collaboration and will support both businesses to meet their goals and aspirations for the future.
If you are interested in finding out more about these businesses visit the below websites:
*Please note that the Leo Cancer Care technologies are not currently available for sale in the US